Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
measured vial content where quantity matters
Retatrutide is an investigational injectable medicine being developed by Eli Lilly and Company for the treatment of obesity and type 2 diabetes
BCVA-Area Under the Curve (AUC) profiles across both RESTORE and REMAIN show fivefold greater vision gains compared to sham treatment
A., Hutter, A
When administered in vitro (dissolved and applied to cell culture systems), the product clearly promote myoblast differentiation and regulate muscle stem cell function, providing a solid theoretical basis for subsequent in vivo studies
US$ 21.43
US$ 28.95
US$ 27.96
US$ 29.74
